Integrated Advisors Network’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Other funds holding IBB
CB
Integrated Advisors Network's IBB Position: Q1 2026 in Review
Integrated Advisors Network reduced its iShares Biotechnology ETF (IBB) stake by 21% in Q1 2026, selling an estimated $97.1K and leaving 2,195 shares worth $371K. The position accounts for 0.02% of the portfolio, ranked #515.
Integrated Advisors Network first reported a position in IBB in Q4 2019 and has held it in 19 quarters since. The position peaked at $1.9M in Q2 2021. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.
- Integrated Advisors Network held 2,195 shares of iShares Biotechnology ETF worth $371K as of Q1 2026.
- Integrated Advisors Network sold 568 iShares Biotechnology ETF shares in Q1 2026, an estimated $97.1K.
- iShares Biotechnology ETF made up 0.02% of Integrated Advisors Network's portfolio in Q1 2026, its #515 holding.
- Integrated Advisors Network first reported a position in iShares Biotechnology ETF in Q4 2019 and has held it in 19 quarters since.
- Integrated Advisors Network's iShares Biotechnology ETF position peaked at $1.9M in Q2 2021.
- 917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.
Based on Integrated Advisors Network's 13F filing for Q1 2026, filed 28 Apr 2026.